Skip to main content

Wagner Charles F Jr's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed Apr 5, 2022

Accession no.
0000899243-22-013708
Filed
Apr 5, 2022
Trade date
Apr 1, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions. Open-market sales total $683.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wagner Charles F JrCIK 0001223348Officer (EVP & Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 1, 2022Common StockSSaleDisposed−300$261.42F2,F3−$78,42645,902Direct
Apr 1, 2022Common StockSSaleDisposed−381$263.67F2,F4−$100,458.2745,521Direct
Apr 1, 2022Common StockSSaleDisposed−1,142$265.06F2,F5−$302,698.5244,379Direct
Apr 1, 2022Common StockSSaleDisposed−536$265.95F2,F6−$142,549.243,843Direct
Apr 1, 2022Common StockSSaleDisposed−223$266.68F2,F7−$59,469.6443,620Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 5 transactions in Table I.

F3

Open market sales reported on this line occurred at a weighted average price of $261.42 (range $261.04 to $261.80).

Referenced by the price of 1 transaction in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $263.67 (range $263.45 to $264.42).

Referenced by the price of 1 transaction in Table I.

F5

Open market sales reported on this line occurred at a weighted average price of $265.06 (range $264.53 to $265.48).

Referenced by the price of 1 transaction in Table I.

F6

Open market sales reported on this line occurred at a weighted average price of $265.95 (range $265.55 to $266.47).

Referenced by the price of 1 transaction in Table I.

F7

Open market sales reported on this line occurred at a weighted average price of $266.68 (range $266.55 to $266.83).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)